First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy by K. Kisielewska, K. Kozak, P. Teterycz, Ł. Galus, J. Mackiewicz, P. Brandys, B. Cybulska-Stopa, N. Kempa-Kamińska, M. Ziętek, J. Żubrowska, R. Dziura, P. Sobczuk, A.M. Czarnecka, P. Rutkowski

Get full text